Richard Lowenthal, M.S., MSEL

2022

In 2022, Richard Lowenthal, M.S., MSEL earned a total compensation of $476.3K as President and Chief Executive Officer at ARS Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$188,076
Salary$74,630
Other$113,642
Total$476,348

MSEL received $188.1K in non-equity incentive plan, accounting for 39% of the total pay in 2022.

MSEL also received $100K in bonus, $74.6K in salary and $113.6K in other compensation.

Rankings

In 2022, Richard Lowenthal, M.S., MSEL's compensation ranked 4,356th out of 5,625 executives tracked by ExecPay. In other words, MSEL earned more than 22.6% of executives.

ClassificationRankingPercentile
All
4,356
out of 5,625
23rd
Division
Manufacturing
2,446
out of 3,053
20th
Major group
Chemicals And Allied Products
1,176
out of 1,380
15th
Industry group
Drugs
1,103
out of 1,281
14th
Industry
Pharmaceutical Preparations
800
out of 927
14th
Source: SEC filing on May 1, 2023.

MSEL's colleagues

We found six more compensation records of executives who worked with Richard Lowenthal, M.S., MSEL at ARS Pharmaceuticals in 2022.

2022

Laura Shawver

ARS Pharmaceuticals

Chief Executive Officer

2022

Valerie Odegard

ARS Pharmaceuticals

Chief Scientific Officer

2022

Jonathan Piazza

ARS Pharmaceuticals

Chief Financial Officer

2022

Jeffrey Pepe

ARS Pharmaceuticals

Chief Executive Officer

2022

Sarina Tanimoto

ARS Pharmaceuticals

Chief Medical Officer

2022

Eric Karas

ARS Pharmaceuticals

Chief Commercial Officer

News

You may also like